Teva Gets Canadian Rituximab Nod, But Barriers May Remain
Executive Summary
Teva has obtained Health Canada clearance for biosimilar rituximab through an alliance with Celltrion. But the Israeli group is keeping quiet on launch plans as patent litigation continues.